RECRUITING

Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to test the effectiveness of the ACCESS strategy: an organizational-level intervention that uses funding and practice facilitation to improve the organizational capacity of syringe services programs (SSPs) to implement routine, opt-out HIV and Hepatitis C (HCV) testing and linkage to care for people who inject drugs (PWID).

Official Title

Project ACCESS: Advancing Access to HIV/HCV Testing Through Transformation in Syringe Services Programs: A Cluster Randomized Trial

Quick Facts

Study Start:2025-06-27

Study Completion:2028-08-01

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06730555

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* SSPs must: 1. be operating in an Ending the HIV Epidemic (EHE) or Centers for Disease Control and Prevention (CDC) determined vulnerable jurisdictions; 2. serve at least 300 unique participants per year; 3. not currently offer opt-out HIV/HCV testing; 4. be capable and willing to prospectively collect aggregated, site-level data on the number of participants who are: i) offered HIV/HCV screening, ii) completed these tests, and iii) linked to care, as well as provide participant demographics; 5. have key staff that consent to participate in study surveys, qualitative interviews and practice facilitation throughout the study.	* SSPs must not: 1. currently receive or have received Frontline Communities in the United States (FOCUS) funding; 2. have already implemented opt-out HIV/HCV testing.

Inclusion Criteria

Exclusion Criteria

* SSPs must:
1. be operating in an Ending the HIV Epidemic (EHE) or Centers for Disease Control and Prevention (CDC) determined vulnerable jurisdictions;
2. serve at least 300 unique participants per year;
3. not currently offer opt-out HIV/HCV testing;
4. be capable and willing to prospectively collect aggregated, site-level data on the number of participants who are: i) offered HIV/HCV screening, ii) completed these tests, and iii) linked to care, as well as provide participant demographics;
5. have key staff that consent to participate in study surveys, qualitative interviews and practice facilitation throughout the study.

* SSPs must not:
1. currently receive or have received Frontline Communities in the United States (FOCUS) funding;
2. have already implemented opt-out HIV/HCV testing.

Contacts and Locations

Study Contact

Hansel Tookes, MD

CONTACT

3056897030

hetookes@miami.edu

Principal Investigator

Tyler Bartholomew, PhD

PRINCIPAL_INVESTIGATOR

University of Miami

Study Locations (Sites)

University of Miami

Miami, Florida, 33136

United States

Collaborators and Investigators

Sponsor: University of Miami

Tyler Bartholomew, PhD, PRINCIPAL_INVESTIGATOR, University of Miami

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-06-27

Study Completion Date2028-08-01

Study Record Updates

Study Start Date2025-06-27

Study Completion Date2028-08-01

Terms related to this study

Additional Relevant MeSH Terms

HIV Infections